[1] |
Hoffman EP, Brown RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 1987, 51(6): 919-928.
|
[2] |
Mercuri E, Bönnemann CG, Muntoni F. Muscular dystrophies. Lancet, 2019, 394(10213): 2025-2038.
doi: S0140-6736(19)32910-1
pmid: 31789220
|
[3] |
Juan-Mateu J, Gonzalez-Quereda L, Rodriguez MJ, Baena M, Verdura E, Nascimento A, Ortez C, Baiget M, Gallano P. DMD mutations in 576 dystrophinopathy families: a step forward in genotype-phenotype correlations. PLoS One, 2015, 10(8): e0135189.
|
[4] |
Ryder S, Leadley RM, Armstrong N, Westwood M, de Kock S, Butt T, Jain M, Kleijnen J. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J Rare Dis, 2017, 12(1): 79.
doi: 10.1186/s13023-017-0631-3
pmid: 28446219
|
[5] |
Kamdar F, Garry DJ. Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol, 2016, 67(21): 2533-2546.
doi: 10.1016/j.jacc.2016.02.081
pmid: 27230049
|
[6] |
Li SY, Sun XF, Li Q, Zhang HM, Wang XM. Association of mutation types and distribution characteristics of dystrophin gene with clinical symptoms in Chinese population. Hereditas(Beijing), 2011, 33(3): 251-254.
|
|
李少英, 孙筱放, 黎青, 张慧敏, 王晓蔓. 中国人群中抗肌萎缩蛋白基因突变类型和分布特点及其与临床症状的相关性. 遗传, 2011, 33(3): 251-254.
|
[7] |
Grain L, Cortina-Borja M, Forfar C, Hilton-Jones D, Hopkin J, Burch M. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls. Neuromuscul Disord, 2001, 11(2): 186-191.
|
[8] |
Ma PP, Dong YL, Wu SW. Relationship between cognitive function and Dp140 expression in children with Duchenne muscular dystrophy. Med J Chin PLA, 2018, 43(11): 950-955.
|
|
马沛沛, 董玉茹, 吴士文. Duchenne型肌营养不良患儿认知功能特点及与Dp140表达的关系. 解放军医学杂志, 2018, 43(11): 950-955.
|
[9] |
Ayarpadikannan S, Lee HE, Han K, Kim HS. Transposable element-driven transcript diversification and its relevance to genetic disorders. Gene, 2015, 558(2): 187-194.
doi: 10.1016/j.gene.2015.01.039
pmid: 25617522
|
[10] |
El-Sheikh AM, Elfar NN, Mourad HA, Hewedy ESS. Relationship between trace elements and premature hair graying. Int J Trichology, 2018, 10(6): 278-283.
doi: 10.4103/ijt.ijt_8_18
pmid: 30783336
|
[11] |
Kumar AB, Shamim H, Nagaraju U. Premature graying of hair: review with updates. Int J Trichology, 2018, 10(5): 198-203.
doi: 10.4103/ijt.ijt_47_18
pmid: 30607038
|
[12] |
Baxter LL, Watkins-Chow DE, Pavan WJ, Loftus SK. A curated gene list for expanding the horizons of pigmentation biology. Pigment Cell Melanoma Res, 2019, 32(3): 348-358.
|
[13] |
Tyers L, Davids LM, Wilmshurst JM, Esterhuizen AI. Skin cells for use in an alternate diagnostic method for Duchenne muscular dystrophy. Neuromuscul Disord, 2018, 28(7): 553-563.
|
[14] |
Tanveer N, Sharma MC, Sarkar C, Gulati S, Kalra V, Singh S, Bhatia R. Diagnostic utility of skin biopsy in dystrophinopathies. Clin Neurol Neurosurg, 2009, 111(6): 496-502.
|
[15] |
Deininger PL, Batzer MA. Alu repeats and human disease. Mol Genet Metab, 1999, 67(3): 183-193.
doi: 10.1006/mgme.1999.2864
pmid: 10381326
|
[16] |
Carroll ML, Roy-Engel AM, Nguyen SV, Salem AH, Vogel E, Vincent B, Myers J, Ahmad Z, Nguyen L, Sammarco M, Watkins WS, Henke J, Makalowski W, Jorde LB, Deininger PL, Batzer MA. Large-scale analysis of the Alu Ya5 and Yb8 subfamilies and their contribution to human genomic diversity. J Mol Biol, 2001, 311(1): 17-40.
doi: 10.1006/jmbi.2001.4847
pmid: 11469855
|
[17] |
Otieno AC, Carter AB, Hedges DJ, Walker JA, Ray DA, Garber RK, Anders BA, Stoilova N, Laborde ME, Fowlkes JD, Huang CH, Perodeau B, Batzer MA. Analysis of the human Alu Ya-lineage. J Mol Biol, 2004, 342(1): 109-118.
pmid: 15313610
|
[18] |
Comeaux MS, Roy-Engel AM, Hedges DJ, Deininger PL. Diverse cis factors controlling Alu retrotransposition: what causes Alu elements to die?. Genome Res, 2009, 19(4): 545-555.
doi: 10.1101/gr.089789.108
pmid: 19273617
|
[19] |
Perez-Stable C, Ayres TM, Shen CK. Distinctive sequence organization and functional programming of an Alu repeat promoter. Proc Natl Acad Sci USA, 1984, 81(17): 5291-5295.
pmid: 6089189
|
[20] |
Jurka J. Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc Natl Acad Sci USA, 1997, 94(5): 1872-1877.
doi: 10.1073/pnas.94.5.1872
pmid: 9050872
|
[21] |
Hancks DC, Kazazian HH. Roles for retrotransposon insertions in human disease. Mob DNA, 2016, 7: 9.
|
[22] |
Roy-Engel AM, Salem AH, Oyeniran OO, Deininger L, Hedges DJ, Kilroy GE, Batzer MA, Deininger PL. Active Alu element "A-tails": size does matter. Genome Res, 2002, 12(9): 1333-1344.
doi: 10.1101/gr.384802
pmid: 12213770
|
[23] |
Dewannieux M, Heidmann T. Role of poly(A) tail length in Alu retrotransposition. Genomics, 2005, 86(3): 378-381.
doi: 10.1016/j.ygeno.2005.05.009
pmid: 15993034
|
[24] |
Batzer MA, Deininger PL. Alu repeats and human genomic diversity. Nat Rev Genet, 2002, 3(5): 370-379.
doi: 10.1038/nrg798
pmid: 11988762
|
[25] |
Ferlini A, Galié N, Merlini L, Sewry C, Branzi A, Muntoni F. A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet, 1998, 63(2): 436-446.
pmid: 9683584
|
[26] |
Torella A, Budillon A, Zanobio M, Del Vecchio Blanco F, Picillo E, Politano L, Nigro V, Piluso G. Alu-mediated insertions in the DMD gene: a difficult puzzle to interpret clinically. Int J Mol Sci, 2023, 24(11): 9241.
|
[27] |
Flanigan KM, Dunn DM, von Niederhausern A, Soltanzadeh P, Howard MT, Sampson JB, Swoboda KJ, Bromberg MB, Mendell JR, Taylor LE, Anderson CB, Pestronk A, Florence JM, Connolly AM, Mathews KD, Wong B, Finkel RS, Bonnemann CG, Day JW, McDonald C, United Dystrophinopathy Project Consortium, Weiss RB. Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene. Hum Mutat, 2011, 32(3): 299-308.
doi: 10.1002/humu.21426
pmid: 21972111
|
[28] |
Bello L, Pegoraro E. Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy. Acta Myol, 2016, 35(3): 122-127.
pmid: 28484312
|
[29] |
Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics, 1988, 2(1): 90-95.
doi: 10.1016/0888-7543(88)90113-9
pmid: 3384440
|
[30] |
Aartsma-Rus A, Van Deutekom JCT, Fokkema IF, Van Ommen GJB, Den Dunnen JT. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve, 2006, 34(2): 135-144.
|
[31] |
Okubo M, Noguchi S, Hayashi S, Nakamura H, Komaki H, Matsuo M, Nishino I. Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy. Hum Genet, 2020, 139(2): 247-255.
|
[32] |
Pellegrini C, Zulian A, Gualandi F, Manzati E, Merlini L, Michelini ME, Benassi L, Marmiroli S, Ferlini A, Sabatelli P, Bernardi P, Maraldi NM. Melanocytes--a novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy. J Cell Physiol, 2013, 228(6): 1323-1231.
doi: 10.1002/jcp.24290
pmid: 23169061
|
[33] |
Körner H, Epanchintsev A, Berking C, Schuler-Thurner B, Speicher MR, Menssen A, Hermeking H. Digital karyotyping reveals frequent inactivation of the dystrophin/ DMD gene in malignant melanoma. Cell Cycle, 2007, 6(2): 189-198.
|